Vaccines usually take years of research and testing before they reach the masses, but scientists in Russia have reported that the Covid-19 vaccine has shown some positives in early-stage trials.
The vaccine, known as “Sputnik-V”, has gone through two trials involving 76 participants, 100% of which developed antibodies to the new coronavirus without serious side effects.
Russia licensed the two-shot jab vaccine for domestic use in August, although it has published no data or large-scale trials.
The next step for this vaccine is now to enter into a powerful advanced trial of 40,000 people.
Hopefully, this major breakthrough in developing a vaccine against Covid-19 will eventually spur the need to return the world to what it was before the pandemic!